T1	Participants 81 99	patients with AIDS
T2	Participants 585 680	(165-microg/injection [35 eyes, 30 patients] and 330-microg/injection [153 eyes, 120 patients])
#1	AnnotatorNotes T2	two groups one -30 patients and other -120 patients
